These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 16167344
1. Enhanced anti-angiogenic effect of a deletion mutant of plasminogen kringle 5 on neovascularization. Cai W, Ma J, Li C, Yang Z, Yang X, Liu W, Liu Z, Li M, Gao G. J Cell Biochem; 2005 Dec 15; 96(6):1254-61. PubMed ID: 16167344 [Abstract] [Full Text] [Related]
2. [A deletion mutant of plasminogen kringle 5 inhibits retinal capillary endothelial cell proliferation]. Ma JF, Yang ZH, Li CY, Cai WB, Song ZH, Guo Y, Guo LL, Li MY, Liu ZG, Gao GQ. Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec 15; 23(12):1245-8. PubMed ID: 14678880 [Abstract] [Full Text] [Related]
3. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3). Chang PC, Chang YJ, Wu HL, Chang CW, Lin CI, Wang WC, Shi GY. Thromb Haemost; 2008 Apr 15; 99(4):729-38. PubMed ID: 18392331 [Abstract] [Full Text] [Related]
4. [Preparation and functional study of an adenovirus vector expressing human plasminogen kringle 5 gene]. Yang J, Wang YX, Guan XQ, Ma CG, Wang LS, Song HY. Sheng Wu Gong Cheng Xue Bao; 2003 Mar 15; 19(2):217-22. PubMed ID: 15966325 [Abstract] [Full Text] [Related]
5. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression. Perri SR, Nalbantoglu J, Annabi B, Koty Z, Lejeune L, François M, Di Falco MR, Béliveau R, Galipeau J. Cancer Res; 2005 Sep 15; 65(18):8359-65. PubMed ID: 16166313 [Abstract] [Full Text] [Related]
6. Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats. Zhang D, Kaufman PL, Gao G, Saunders RA, Ma JX. Diabetologia; 2001 Jun 15; 44(6):757-65. PubMed ID: 11440369 [Abstract] [Full Text] [Related]
7. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization. Zhang Z, Ma JX, Gao G, Li C, Luo L, Zhang M, Yang W, Jiang A, Kuang W, Xu L, Chen J, Liu Z. Invest Ophthalmol Vis Sci; 2005 Nov 15; 46(11):4062-71. PubMed ID: 16249481 [Abstract] [Full Text] [Related]
8. Kringle 5 of human plasminogen suppresses hepatocellular carcinoma growth both in grafted and xenografted mice by anti-angiogenic activity. Yang X, Cheng R, Li C, Cai W, Ma JX, Liu Q, Yang Z, Song Z, Liu Z, Gao G. Cancer Biol Ther; 2006 Apr 15; 5(4):399-405. PubMed ID: 16481742 [Abstract] [Full Text] [Related]
9. Acidic/neutral amino acid residues substitution in NH2 terminal of plasminogen kringle 5 exerts enhanced effects on corneal neovascularization. Li C, Li L, Cheng R, Dai Z, Li C, Yao Y, Zhou T, Yang Z, Gao G, Yang X. Cornea; 2013 May 15; 32(5):680-8. PubMed ID: 23343948 [Abstract] [Full Text] [Related]
10. Systemic and periocular deliveries of plasminogen kringle 5 reduce vascular leakage in rat models of oxygen-induced retinopathy and diabetes. Zhang SX, Sima J, Wang JJ, Shao C, Fant J, Ma JX. Curr Eye Res; 2005 Aug 15; 30(8):681-9. PubMed ID: 16109649 [Abstract] [Full Text] [Related]
11. Lentivirus-mediated expression of angiostatin efficiently inhibits neovascularization in a murine proliferative retinopathy model. Igarashi T, Miyake K, Kato K, Watanabe A, Ishizaki M, Ohara K, Shimada T. Gene Ther; 2003 Feb 15; 10(3):219-26. PubMed ID: 12571629 [Abstract] [Full Text] [Related]
12. Nanoparticle-mediated expression of an angiogenic inhibitor ameliorates ischemia-induced retinal neovascularization and diabetes-induced retinal vascular leakage. Park K, Chen Y, Hu Y, Mayo AS, Kompella UB, Longeras R, Ma JX. Diabetes; 2009 Aug 15; 58(8):1902-13. PubMed ID: 19491211 [Abstract] [Full Text] [Related]
13. Kringle 5 of human plasminogen induces apoptosis of endothelial and tumor cells through surface-expressed glucose-regulated protein 78. Davidson DJ, Haskell C, Majest S, Kherzai A, Egan DA, Walter KA, Schneider A, Gubbins EF, Solomon L, Chen Z, Lesniewski R, Henkin J. Cancer Res; 2005 Jun 01; 65(11):4663-72. PubMed ID: 15930284 [Abstract] [Full Text] [Related]
14. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli. You WK, So SH, Sohn YD, Lee H, Park DH, Chung SI, Chung KH. Protein Expr Purif; 2004 Jul 01; 36(1):1-10. PubMed ID: 15177278 [Abstract] [Full Text] [Related]
15. Plasminogen kringle 5 reduces vascular leakage in the retina in rat models of oxygen-induced retinopathy and diabetes. Zhang SX, Sima J, Shao C, Fant J, Chen Y, Rohrer B, Gao G, Ma JX. Diabetologia; 2004 Jan 01; 47(1):124-31. PubMed ID: 14666366 [Abstract] [Full Text] [Related]
16. Increased suppression of oncolytic adenovirus carrying mutant k5 on colorectal tumor. Fan JK, Xiao T, Gu JF, Wei N, He LF, Ding M, Liu XY. Biochem Biophys Res Commun; 2008 Sep 19; 374(2):198-203. PubMed ID: 18621025 [Abstract] [Full Text] [Related]
17. High efficacy and minimal peptide required for the anti-angiogenic and anti-hepatocarcinoma activities of plasminogen K5. Yang X, Cai W, Xu Z, Chen J, Li C, Liu S, Yang Z, Pan Q, Li M, Ma J, Gao G. J Cell Mol Med; 2010 Oct 19; 14(10):2519-30. PubMed ID: 20050964 [Abstract] [Full Text] [Related]
18. Anti-angiogenic function of tocotrienol. Miyazawa T, Shibata A, Nakagawa K, Tsuzuki T. Asia Pac J Clin Nutr; 2008 Oct 19; 17 Suppl 1():253-6. PubMed ID: 18296349 [Abstract] [Full Text] [Related]
19. Expression of biologically active kringle 5 domain of human plasminogen in Escherichia coli. Zhang HX, Fang L, Cheng J, Wei Z, Hua ZC. Prep Biochem Biotechnol; 2005 Oct 19; 35(1):17-27. PubMed ID: 15704494 [Abstract] [Full Text] [Related]
20. High level expression of kringle 5 fragment of plasminogen in Pichia pastoris. Zhou Y, Zheng Q, Gao J, Gu J. Biotechnol Lett; 2005 Feb 19; 27(3):167-71. PubMed ID: 15717125 [Abstract] [Full Text] [Related] Page: [Next] [New Search]